Go Pro

SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$4.00 +0.32 (+8.70%)
As of 08/21/2026 04:00 PM Eastern

SBC vs. OMDA, INNV, PNTG, AMN, and LMRI

Should you buy SBC Medical Group stock or one of its competitors? SBC Medical Group's main competitors and comparable companies include Omada Health (OMDA), InnovAge (INNV), The Pennant Group (PNTG), AMN Healthcare Services (AMN), and Lumexa Imaging (LMRI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does SBC Medical Group compare to Omada Health?

Omada Health (NASDAQ:OMDA) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

SBC Medical Group has a net margin of 27.99% compared to Omada Health's net margin of 1.39%. SBC Medical Group's return on equity of 18.47% beat Omada Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Omada Health1.39% 2.60% 1.98%
SBC Medical Group 27.99%18.47%13.10%

Omada Health has a beta of 1.73, indicating that its share price is 73% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

In the previous week, SBC Medical Group had 16 more articles in the media than Omada Health. MarketBeat recorded 21 mentions for SBC Medical Group and 5 mentions for Omada Health. Omada Health's average media sentiment score of 1.03 beat SBC Medical Group's score of 0.51 indicating that Omada Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omada Health
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

60.8% of SBC Medical Group shares are held by institutional investors. 6.4% of Omada Health shares are held by company insiders. Comparatively, 81.7% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Omada Health presently has a consensus target price of $26.50, suggesting a potential upside of 10.93%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 112.50%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omada Health
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has lower revenue, but higher earnings than Omada Health. SBC Medical Group is trading at a lower price-to-earnings ratio than Omada Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omada Health$260.21M5.62-$12.78M$0.05477.80
SBC Medical Group$173.61M2.36$50.99M$0.478.51

Summary

SBC Medical Group beats Omada Health on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to InnovAge?

InnovAge (NASDAQ:INNV) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

SBC Medical Group has lower revenue, but higher earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InnovAge$853.70M1.74-$30.31M-$0.09N/A
SBC Medical Group$173.61M2.36$50.99M$0.478.51

12.3% of InnovAge shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 1.0% of InnovAge shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

SBC Medical Group has a net margin of 27.99% compared to InnovAge's net margin of -1.22%. SBC Medical Group's return on equity of 18.47% beat InnovAge's return on equity.

Company Net Margins Return on Equity Return on Assets
InnovAge-1.22% -4.73% -2.20%
SBC Medical Group 27.99%18.47%13.10%

In the previous week, SBC Medical Group had 12 more articles in the media than InnovAge. MarketBeat recorded 21 mentions for SBC Medical Group and 9 mentions for InnovAge. InnovAge's average media sentiment score of 1.16 beat SBC Medical Group's score of 0.51 indicating that InnovAge is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InnovAge
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

InnovAge has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

InnovAge presently has a consensus target price of $10.00, suggesting a potential downside of 8.76%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 112.50%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than InnovAge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InnovAge
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

SBC Medical Group beats InnovAge on 14 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to The Pennant Group?

SBC Medical Group (NASDAQ:SBC) and The Pennant Group (NASDAQ:PNTG) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by insiders. Comparatively, 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

SBC Medical Group has higher earnings, but lower revenue than The Pennant Group. SBC Medical Group is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M2.36$50.99M$0.478.51
The Pennant Group$947.71M1.43$29.58M$0.9043.20

SBC Medical Group presently has a consensus target price of $8.50, indicating a potential upside of 112.50%. The Pennant Group has a consensus target price of $41.60, indicating a potential upside of 7.00%. Given SBC Medical Group's higher possible upside, research analysts plainly believe SBC Medical Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

SBC Medical Group has a net margin of 27.99% compared to The Pennant Group's net margin of 2.93%. SBC Medical Group's return on equity of 18.47% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
The Pennant Group 2.93%10.33%4.20%

SBC Medical Group has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

In the previous week, SBC Medical Group had 12 more articles in the media than The Pennant Group. MarketBeat recorded 21 mentions for SBC Medical Group and 9 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.98 beat SBC Medical Group's score of 0.51 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SBC Medical Group
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

SBC Medical Group and The Pennant Group tied by winning 8 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

SBC Medical Group has lower revenue, but higher earnings than AMN Healthcare Services. SBC Medical Group is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.87
SBC Medical Group$173.61M2.36$50.99M$0.478.51

AMN Healthcare Services currently has a consensus price target of $31.43, indicating a potential downside of 8.85%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 112.50%. Given SBC Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

SBC Medical Group has a net margin of 27.99% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat SBC Medical Group's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
SBC Medical Group 27.99%18.47%13.10%

In the previous week, SBC Medical Group had 14 more articles in the media than AMN Healthcare Services. MarketBeat recorded 21 mentions for SBC Medical Group and 7 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 0.72 beat SBC Medical Group's score of 0.51 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

SBC Medical Group beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Lumexa Imaging?

SBC Medical Group (NASDAQ:SBC) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 112.50%. Lumexa Imaging has a consensus target price of $16.00, suggesting a potential upside of 28.82%. Given SBC Medical Group's higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Lumexa Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Lumexa Imaging
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

SBC Medical Group has a net margin of 27.99% compared to Lumexa Imaging's net margin of 0.00%. SBC Medical Group's return on equity of 18.47% beat Lumexa Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.47% 13.10%
Lumexa Imaging N/A N/A N/A

In the previous week, SBC Medical Group had 21 more articles in the media than Lumexa Imaging. MarketBeat recorded 21 mentions for SBC Medical Group and 0 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.93 beat SBC Medical Group's score of 0.51 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
SBC Medical Group Positive
Lumexa Imaging Positive

SBC Medical Group has higher earnings, but lower revenue than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M2.36$50.99M$0.478.51
Lumexa Imaging$267.73M4.46-$47.10M-$0.49N/A

60.8% of SBC Medical Group shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

SBC Medical Group beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$410.31M$9.83B$7.37B$12.85B
Dividend YieldN/A2.55%2.53%11.08%
P/E Ratio8.5134.38272.8824.24
Price / Sales2.364.97618.9699.81
Price / Cash7.64125.1278.6253.99
Price / Book1.474.0513.056.20
Net Income$50.99M$311.06M$3.47B$348.59M
7 Day Performance9.29%0.83%2.09%0.08%
1 Month Performance36.52%2.42%6.64%3.88%
1 Year Performance-6.76%15.69%25.02%16.98%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
4.0795 of 5 stars
$4.00
+8.7%
$8.50
+112.5%
-6.8%$410.31M$173.61M8.51N/A
OMDA
Omada Health
3.2295 of 5 stars
$24.23
+2.0%
$26.50
+9.4%
+12.1%$1.48B$309.76M484.50849
INNV
InnovAge
2.1659 of 5 stars
$10.88
-2.0%
$7.00
-35.6%
+193.0%$1.48B$853.70MN/A2,440
PNTG
The Pennant Group
4.2326 of 5 stars
$39.21
-0.5%
$41.20
+5.1%
+54.5%$1.37B$947.71M43.579,700
AMN
AMN Healthcare Services
1.9194 of 5 stars
$35.31
+2.2%
$31.43
-11.0%
+66.7%$1.37B$3.43B13.182,664

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners